Epidural hematoma after total knee arthroplasty in a patient receiving rivaroxaban: A case report
Anesthesia and Pain Medicine
;
: 102-105, 2019.
Artigo
em Inglês
| WPRIM
| ID: wpr-719395
ABSTRACT
Rivaroxaban, a factor Xa inhibitor, is one of the newly developed direct oral anticoagulants (DOAC). In recent times, it has been increasingly used in the prevention of pulmonary embolism in patients undergoing orthopedic surgery. This report describes a case of epidural hematoma in an elderly patient who underwent combined spinal epidural anesthesia for total knee arthroplasty; the patient received rivaroxaban postoperatively for 7 days to prevent pulmonary embolism. Additionally, the epidural hematomas developed on the 5th postoperative day but the patient recovered well with conservative treatment. Although rivaroxaban has a low need for monitoring and is easily administered, the guidelines should be carefully checked for the postoperative administration schedule in patients undergoing regional anesthesia. In addition, rivaroxaban should be used with caution, especially in elderly patients.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Ortopedia
/
Agendamento de Consultas
/
Embolia Pulmonar
/
Fator Xa
/
Artroplastia do Joelho
/
Hematoma Epidural Espinal
/
Rivaroxabana
/
Hematoma
/
Anestesia por Condução
/
Anestesia Epidural
Tipo de estudo:
Guia de Prática Clínica
Limite:
Idoso
/
Humanos
Idioma:
Inglês
Revista:
Anesthesia and Pain Medicine
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS